ClostraBio Raises $3.5M in its Quest to Prevent Food Allergies
ClostraBio, a Chicago startup creating a drug that aims to prevent allergic reactions to food, has raised a $3.5 million seed round.
Born out of the University of Chicago, ClostraBio is creating some of the first drugs to prevent and treat food allergies. The startup’s goal is to make drugs that boost the body’s natural intestinal barrier, stopping the reaction before it starts. It’s initially working to solve peanut and milk allergies.
Investors in the round include Morningstar founder Joe Mansueto and the University of Chicago. Additionally, two families—based in Chicago and Virginia—that have children who suffer from severe food allergies, also invested in ClostraBio’s round.
Article:
https://www.americaninno.com/chicago...ood-allergies/
Delivery Logistics Startup Bringg Raises $12M
Delivery logistics startup Bringg raised $12 million, bringing its total Series B funding to $22 million, the company announced Tuesday.
Investors in the round included Salesforce Ventures, automotive investor Shmuel Harlap and real estate and shipping magnate Eyal Ofer. The company says the new funding will help the company expand its international presence. Bringg now has $31 million in total funding, according to Crunchbase.
Bringg, which has offices in Chicago, New York and Tel Aviv, helps their customers digitize their supply chain to help create a more efficient delivery ecosystem across industries. They have clients in retail, e-commerce and food markets, and they span across more than 50 countries. Some of them include Coca-Cola, Panera Bread and Hilti.
Article:
https://www.americaninno.com/chicago...gg-raises-12m/
Evive ditches bootstraps with $43M in fresh funding
Evive, a Chicago-based startup whose technology makes it easier to understand and use employee benefits, announced on Thursday that it has landed $43 million in fresh funding.
The startup will use the funding to expand its team and boost product development.
“For a team that’s been mission-driven from day one, Evive is thrilled by what this funding will mean for our clients as we further invest in our technology platform,” said CEO Prashant Srivastava in a statement. “Our clients rely on us to help solve their most pressing benefits issues, and these increasingly are best accomplished with smart and innovative technologies.”
Susquehanna Growth Equity led the investment, which is Evive’s first round of outside funding. Susquehanna’s other portfolio companies include Credit Karma, Outbrain and Buildout.
Article:
https://www.builtinchicago.org/2018/...-fresh-funding